The DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index.
Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Green, D. R., & Reed, J. C. (1998) · Science · doi:10.1126/science.281.5381.1309 · Cited by 8,965
Danial, N. N., & Korsmeyer, S. J. (2004) · Cell · doi:10.1016/s0092-8674(04)00046-7 · Cited by 4,651
Cellular processing of platinum anticancer drugs
Wang, D., & Lippard, S. J. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1691 · Cited by 3,801
Cisplatin: mode of cytotoxic action and molecular basis of resistance
Siddik, Z. H. (2003) · Oncogene · doi:10.1038/sj.onc.1206933 · Cited by 3,335
Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode
ROSENBERG, B., VAN CAMP, L., & KRIGAS, T. (1965) · Nature · doi:10.1038/205698a0 · Cited by 3,049
MAP kinase signalling pathways in cancer
Dhillon, A. S., Hagan, S., Rath, O., & Kolch, W. (2007) · Oncogene · doi:10.1038/sj.onc.1210421 · Cited by 2,995
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
Jamieson, E. R., & Lippard, S. J. (1999) · Chemical Reviews · doi:10.1021/cr980421n · Cited by 2,949
Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis
Chipuk, J. E., Kuwana, T., Bouchier-Hayes, L., Droin, N. M., Newmeyer, D. D., Schuler, M., & Green, D. R. (2004) · Science · doi:10.1126/science.1092734 · Cited by 2,108 · cited 1×
“It is noteworthy that, in addition to gene transcription, p53 may also induce apoptosis by directly activating proapoptotic Bcl-2 family proteins, leading to mitochondrial injury and the release of apoptogenic factors.(81) Whether the direct mechanism is involved in cisplatin-induced renal tubular cell death is unknow…”
BackgroundStrasser, A., O'Connor, L., & Dixit, V. M. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.217 · Cited by 1,351
Update on Mechanisms of Ischemic Acute Kidney Injury
Devarajan, P. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006010017 · Cited by 1,026
Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals
Ishida, S., Lee, J., Thiele, D. J., & Herskowitz, I. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162491399 · Cited by 927
Arany, I., & Safirstein, R. L. (2003) · Seminars in Nephrology · doi:10.1016/s0270-9295(03)00089-5 · Cited by 906
Mechanisms of resistance to cisplatin
Kartalou, M., & Essigmann, J. M. (2001) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(01)00141-5 · Cited by 869
TNF-α mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity
Ramesh, G., & Reeves, W. B. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15606 · Cited by 866
Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases
Owens, D. M., & Keyse, S. M. (2007) · Oncogene · doi:10.1038/sj.onc.1210412 · Cited by 777
Recent Advances in the Pathophysiology of Ischemic Acute Renal Failure
Bonventre, J. V., & Weinberg, J. M. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000079785.13922.f6 · Cited by 767
Cellular response to endoplasmic reticulum stress: a matter of life or death
Boyce, M., & Yuan, J. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401817 · Cited by 680
Cisplatin: From DNA damage to cancer chemotherapy
Cohen, S. M., & Lippard, S. J. (2001) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(01)67026-0 · Cited by 615
Cellular accumulation of the anticancer agent cisplatin: A review
Gately, D., & Howell, S. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.221 · Cited by 572
Eastman, A. (1987) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(87)90009-x · Cited by 539
Cisplatin and DNA repair in cancer chemotherapy
Zamble, D. B., & Lippard, S. J. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)89095-7 · Cited by 538
Gene Expression Levels and Immunolocalization of Organic Ion Transporters in the Human Kidney
Motohashi, H., Sakurai, Y., Saito, H., Masuda, S., Urakami, Y., Goto, M., Fukatsu, A., Ogawa, O., & Inui, K.-I. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v134866 · Cited by 508
Multiple levels of cyclin specificity in cell-cycle control
Bloom, J., & Cross, F. R. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2105 · Cited by 503
Lieberthal, W., Triaca, V., & Levine, J. (1996) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1996.270.4.f700 · Cited by 449
Cisplatin Nephrotoxicity Is Critically Mediated via the Human Organic Cation Transporter 2
Ciarimboli, G., Ludwig, T., Lang, D., Pavenstädt, H., Koepsell, H., Piechota, H.-J., Haier, J., Jaehde, U., Zisowsky, J., & Schlatter, E. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61234-5 · Cited by 448
OXIDANT MECHANISMS IN TOXIC ACUTE RENAL FAILURE*
BALIGA, R., UEDA, N., WALKER, P. D., & SHAH, S. V. (1999) · Drug Metabolism Reviews · doi:10.1081/dmr-100101947 · Cited by 426
Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury
Deng, J., Kohda, Y., Chiao, H., Wang, Y., Hu, X., Hewitt, S. M., Miyaji, T., Mcleroy, P., Nibhanupudy, B., Li, S., et al. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00043.x · Cited by 399
Faubel, S., Lewis, E. C., Reznikov, L., Ljubanovic, D., Hoke, T. S., Somerset, H., Oh, D.-J., Lu, L., Klein, C. L., Dinarello, C. A., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.119792 · Cited by 399
Nazıroğlu, M., Karaoğlu, A., & Aksoy, A. (2003) · Toxicology · doi:10.1016/j.tox.2003.10.012 · Cited by 370
Cisplatin-Induced Renal Cell Apoptosis: Caspase 3-Dependent and -Independent Pathways
Cummings, B. S., & Schnellmann, R. G. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.1.8 · Cited by 358
A Death-Promoting Role for Extracellular Signal-Regulated Kinase
Zhuang, S., & Schnellmann, R. G. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.107367 · Cited by 355
Bak regulates mitochondrial morphology and pathology during apoptosis by interacting with mitofusins
Brooks, C., Wei, Q., Feng, L., Dong, G., Tao, Y., Mei, L., Xie, Z.-J., & Dong, Z. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703976104 · Cited by 351
Self-citationKruidering, M., Van De Water, B., De Heer, E., Mulder, G. J., & Nagelkerke, J. F. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36493-6 · Cited by 325
Metabolism of Cisplatin to a Nephrotoxin in Proximal Tubule Cells
Townsend, D. M., Deng, M., Zhang, L., Lapus, M. G., & Hanigan, M. H. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000042803.28024.92 · Cited by 317
Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis
Shiraishi, F., Curtis, L. M., Truong, L., Poss, K., Visner, G. A., Madsen, K., Nick, H. S., & Agarwal, A. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.278.5.f726 · Cited by 315
Zhang, B., Ramesh, G., Norbury, C. C., & Reeves, W. B. (2007) · Kidney International · doi:10.1038/sj.ki.5002242 · Cited by 309
ATR-Chk2 Signaling in p53 Activation and DNA Damage Response during Cisplatin-induced Apoptosis
Pabla, N., Huang, S., Mi, Q.-S., Daniel, R., & Dong, Z. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707568200 · Cited by 309
Self-citationEffects of lycopene against cisplatin-induced nephrotoxicity and oxidative stress in rats
Atessahin, A., Yilmaz, S., Karahan, I., Ceribasi, A. O., & Karaoglu, A. (2005) · Toxicology · doi:10.1016/j.tox.2005.04.016 · Cited by 308
Neuroprotective Effect of Vitamin E Supplementation in Patients Treated With Cisplatin Chemotherapy
Pace, A., Savarese, A., Picardo, M., Maresca, V., Pacetti, U., Del Monte, G., Biroccio, A., Leonetti, C., Jandolo, B., Cognetti, F., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.139 · Cited by 307
Kondo, Y., & Kondo, S. (2006) · Autophagy · doi:10.4161/auto.2.2.2463 · Cited by 305 · cited 1×
“In addition, autophagic cell death occurs independent of caspases.(69,70) Whether cisplatin induces autophagy and whether autophagy is involved in cisplatin-induced cell death is an interesting area for future investigation.”
BackgroundIn vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity
Baliga, R., Zhang, Z., Baliga, M., Ueda, N., & Shah, S. V. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00767.x · Cited by 297
The roles of copper transporters in cisplatin resistance
Kuo, M. T., Chen, H. H. W., Song, I.-S., Savaraj, N., & Ishikawa, T. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9045-3 · Cited by 283
TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure
Ramesh, G., & Reeves, W. B. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00101.2003 · Cited by 282
Cisplatin Induces Apoptosis in LLC-PK1 Cells via Activation of Mitochondrial Pathways
Park, M. S., De Leon, M., & Devarajan, P. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v134858 · Cited by 279
Megyesi, J., Safirstein, R. L., & Price, P. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1497 · Cited by 272
Renal Response to Tissue Injury: Lessons from Heme Oxygenase-1 Gene Ablation and Expression
AGARWAL, A., & NICK, H. S. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v115965 · Cited by 272
Nephrotoxicity and Hydration Management for Cisplatin, Carboplatin, and Ormaplatin
Cornelison, T. L., & Reed, E. (1993) · Gynecologic Oncology · doi:10.1006/gyno.1993.1184 · Cited by 270
p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice
Ramesh, G., & Reeves, W. B. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00401.2004 · Cited by 267
Nowak, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206373200 · Cited by 265
Agarwal, A., Balla, J., Alam, J., Croatt, A. J., & Nath, K. A. (1995) · Kidney International · doi:10.1038/ki.1995.414 · Cited by 260
Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs
Safaei, R., & Howell, S. B. (2005) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2004.09.007 · Cited by 254
Weijl, N. I., Elsendoorn, T. J., Lentjes, E. G. W. M., Hopman, G. D., Wipkink-Bakker, A., Zwinderman, A. H., Cleton, F. J., & Osanto, S. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.02.029 · Cited by 251
Minocycline Up-regulates Bcl-2 and Protects against Cell Death in Mitochondria
Wang, J., Wei, Q., Wang, C.-Y., Hill, W. D., Hess, D. C., & Dong, Z. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313629200 · Cited by 242
Self-citationTsuruya, K., Ninomiya, T., Tokumoto, M., Hirakawa, M., Masutani, K., Taniguchi, M., Fukuda, K., Kanai, H., Kishihara, K., Hirakata, H., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00709.x · Cited by 241
Jo, S.-K., Cho, W. Y., Sung, S. A., Kim, H. K., & Won, N. H. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.67102.x · Cited by 235
Activation and involvement of p53 in cisplatin-induced nephrotoxicity
Wei, Q., Dong, G., Yang, T., Megyesi, J., Price, P. M., & Dong, Z. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00230.2007 · Cited by 232
Self-citationThe pathological role of Bax in cisplatin nephrotoxicity
Wei, Q., Dong, G., Franklin, J., & Dong, Z. (2007) · Kidney International · doi:10.1038/sj.ki.5002256 · Cited by 228
Self-citationDickey, D. T., Wu, Y. J., Muldoon, L. L., & Neuwelt, E. A. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.087601 · Cited by 219
Copper Transport Protein (Ctr1) Levels in Mice Are Tissue Specific and Dependent on Copper Status
Kuo, Y.-M., Gybina, A. A., Pyatskowit, J. W., Gitschier, J., & Prohaska, J. R. (2006) · The Journal of Nutrition · doi:10.1093/jn/136.1.21 · Cited by 218
Caspase Inhibitors Promote Alternative Cell Death Pathways
Vandenabeele, P., Vanden Berghe, T., & Festjens, N. (2006) · Science's STKE · doi:10.1126/stke.3582006pe44 · Cited by 215
Cisplatin-induced cell death is EGFR/src/ERK signaling dependent in mouse proximal tubule cells
Arany, I., Megyesi, J. K., Kaneto, H., Price, P. M., & Safirstein, R. L. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00112.2004 · Cited by 215
Regulation of PUMA-α by p53 in cisplatin-induced renal cell apoptosis
Jiang, M., Wei, Q., Wang, J., Du, Q., Yu, J., Zhang, L., & Dong, Z. (2006) · Oncogene · doi:10.1038/sj.onc.1209440 · Cited by 209
Self-citationInflammatory cytokines in acute renal failure
Ramesh, G., & Reeves, W. B. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.09109.x · Cited by 208
Ciccarelli, R. B., Solomon, M. J., Varshavsky, A., & Lippard, S. J. (1985) · Biochemistry · doi:10.1021/bi00347a005 · Cited by 205
Salicylate reduces cisplatin nephrotoxicity by inhibition of tumor necrosis factor-α
Ramesh, G., & Reeves, W. B. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00413.x · Cited by 196
Faubel, S., Ljubanovic, D., Reznikov, L., Somerset, H., Dinarello, C. A., & Edelstein, C. L. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.66010.x · Cited by 196
Endoplasmic Reticulum Stress–Associated Caspase 12 Mediates Cisplatin-Induced LLC-PK1 Cell Apoptosis
Liu, H., & Baliga, R. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004090768 · Cited by 182
A Pathophysiologic Role for T Lymphocytes in Murine Acute Cisplatin Nephrotoxicity
Liu, M., Chien, C.-C., Burne-Taney, M., Molls, R. R., Racusen, L. C., Colvin, R. B., & Rabb, H. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010102 · Cited by 182
Yonezawa, A., Masuda, S., Nishihara, K., Yano, I., Katsura, T., & Inui, K.-I. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.09.020 · Cited by 180
Nephrotoxicity of platinum complexes is related to basolateral organic cation transport
Ludwig, T., Riethmüller, C., Gekle, M., Schwerdt, G., & Oberleithner, H. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00720.x · Cited by 179
The effects of oral glutamine on cisplatin-induced nephrotoxicity in rats
Mora, L. (2003) · Pharmacological Research · doi:10.1016/s1043-6618(03)00040-9 · Cited by 175
DNA Damage-Dependent Cell Cycle Checkpoints and Genomic Stability
Ishikawa, K., Ishii, H., & Saito, T. (2006) · DNA and Cell Biology · doi:10.1089/dna.2006.25.406 · Cited by 175
Role of p53 in cisplatin-induced tubular cell apoptosis: dependence on p53 transcriptional activity
Jiang, M., Yi, X., Hsu, S., Wang, C.-Y., & Dong, Z. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00262.2004 · Cited by 175
Self-citationSeth, R., Yang, C., Kaushal, V., Shah, S. V., & Kaushal, G. P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503305200 · Cited by 173
Liu, H., & Baliga, R. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00908.x · Cited by 171
Role of ERK activation in cisplatin‐induced apoptosis in OK renal epithelial cells
Kim, Y. K., Kim, H. J., Kwon, C. H., Kim, J. H., Woo, J. S., Jung, J. S., & Kim, J. M. (2005) · Journal of Applied Toxicology · doi:10.1002/jat.1081 · Cited by 167
Santos, N. A. G., Bezerra, C. S. C., Martins, N. M., Curti, C., Bianchi, M. L. P., & Santos, A. C. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-007-0459-y · Cited by 165
Protective effects of vitamin E and C on cisplatin nephrotoxicity in developing rats
Appenroth, D., Fröb, S., Kersten, L., Splinter, F. K., & Winnefeld, K. (1997) · Archives of Toxicology · doi:10.1007/s002040050444 · Cited by 161
Zunino, F., Pratesi, G., Micheloni, A., Cavalletti, E., Sala, F., & Tofanetti, O. (1989) · Chemico-Biological Interactions · doi:10.1016/0009-2797(89)90065-3 · Cited by 156
Protective Effects of Capsaicin against Cisplatin-Induced Nephrotoxicity in Rats
Shimeda, Y., Hirotani, Y., Akimoto, Y., Shindou, K., Ijiri, Y., Nishihori, T., & Tanaka, K. (2005) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.28.1635 · Cited by 156
The p53-independent activation of transcription of p21 WAF1/CIP1/SDI1 after acute renal failure
Megyesi, J. K., Udvarhelyi, N., Safirstein, R. L., & Price, P. M. (1996) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1996.271.6.f1211 · Cited by 153
Lee, R. H., Song, J. M., Park, M. Y., Kang, S. K., Kim, Y. K., & Jung, J. S. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00748-1 · Cited by 150
Jiang, M., Wei, Q., Pabla, N., Dong, G., Wang, C., Yang, T., Smith, S. B., & Dong, Z. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.01.010 · Cited by 149
Self-citationPeyrou, M., Hanna, P. E., & Cribb, A. E. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm152 · Cited by 141
Protection of renal cells from cisplatin toxicity by cell cycle inhibitors
Price, P. M., Safirstein, R. L., & Megyesi, J. K. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00192.2003 · Cited by 134
Anti-inflammatory effect of fibrate protects from cisplatin-induced ARF
Li, S., Gökden, N., Okusa, M. D., Bhatt, R., & Portilla, D. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00038.2005 · Cited by 132
Molecular mechanisms of platinum resistance: still searching for the Achilles? heel
Wernyj, R. P., & Morin, P. J. (2004) · Drug Resistance Updates · doi:10.1016/j.drup.2004.08.002 · Cited by 129
Synergy between PPARγ Ligands and Platinum-Based Drugs in Cancer
Girnun, G. D., Naseri, E., Vafai, S. B., Qu, L., Szwaya, J. D., Bronson, R. T., Alberta, J. A., & Spiegelman, B. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.02.025 · Cited by 128
Townsend, D. M., & Hanigan, M. H. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.1.142 · Cited by 124
Protection against cisplatin-induced nephrotoxicity by a carbon monoxide-releasing molecule
Tayem, Y. I., Johnson, T. R., Mann, B. E., Green, C. J., & Motterlini, R. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00363.2005 · Cited by 122
Fibrate prevents cisplatin-induced proximal tubule cell death.
Nagothu, K. K., Bhatt, R., Kaushal, G., & Portilla, D. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00739.x · Cited by 111
Dependence of Cisplatin-Induced Cell Death In Vitro and In Vivo on Cyclin-Dependent Kinase 2
Price, P. M., Yu, F. Z., Kaldis, P., Aleem, E. A., Nowak, G. D. A., Safirstein, R. L., & Megyesi, J. K. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006020162 · Cited by 111
Role of cytochrome P-450 as a source of catalytic iron in cisplatin-induced nephrotoxicity
Baliga, R., Zhang, Z., Baliga, M., Ueda, N., & Shah, S. V. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00161.x · Cited by 110
The development of platinum compounds and their possible combination
Pasetto, L. M., D'Andrea, M. R., Brandes, A. A., Rossi, E. G., & Monfardini, S. (2006) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2006.02.003 · Cited by 109
Rosiglitazone ameliorates cisplatin-induced renal injury in mice
Lee, S., Kim, W. K., Moon, S.-O., Sung, M. J., Kim, D. H., Kang, K. P., Jang, Y. B., Lee, J. E., Jang, K. Y., & Park, S. K. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl194 · Cited by 108
Tsuruya, K., Tokumoto, M., Ninomiya, T., Hirakawa, M., Masutani, K., Taniguchi, M., Fukuda, K., Kanai, H., Hirakata, H., & Iida, M. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00311.2002 · Cited by 107
Heiger-Bernays, W. J., Essigmann, J. M., & Lippard, S. J. (1990) · Biochemistry · doi:10.1021/bi00488a037 · Cited by 105
γ-Glutamyl Transpeptidase-Deficient Mice Are Resistant to the Nephrotoxic Effects of Cisplatin
Hanigan, M. H., Lykissa, E. D., Townsend, D. M., Ou, C., Barrios, R. J., & Lieberman, M. W. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63035-0 · Cited by 104
Cellular and molecular studies on cisplatin-induced apoptotic cell death in rat kidney
Sheikh‐Hamad, D., Cacini, W., Buckley, A. R., Isaac, J. C., Truong, L. D., Tsao, C. C., & Kishore, B. K. (2004) · Archives of Toxicology · doi:10.1007/s00204-003-0521-4 · Cited by 97
Nutlin-3 protects kidney cells during cisplatin therapy by suppressing Bax/Bak activation
Jiang, M., Pabla, N., Murphy, R. F., Yang, T., Yin, X.-M., Degenhardt, K., White, E., & Dong, Z. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m606928200 · Cited by 97
Self-citationLi, S., Bhatt, R., Megyesi, J. K., Gökden, N., Shah, S. V., & Portilla, D. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00206.2004 · Cited by 94
Caspases and calpain are independent mediators of cisplatin-induced endothelial cell necrosis
Dursun, B., He, Z., Somerset, H., Oh, D., Faubel, S. G., & Edelstein, C. L. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00455.2005 · Cited by 92
Effect of JNK inhibition on cisplatin-induced renal damage
Francescato, H. D. C., Costa, R. S., Junior, F. B., & Coimbra, T. M. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm144 · Cited by 91
Protective effect of cyclic AMP against cisplatin-induced nephrotoxicity
Mishima, K., Baba, A., Matsuo, M., Itoh, Y., & Oishi, R. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.12.025 · Cited by 90
A novel chaperone-activity-reducing mechanism of the 90-kDa molecular chaperone HSP90
Itoh, H., Ogura, M., Komatsuda, A., Wakui, H., MIURA, A. B., & Tashima, Y. (1999) · Biochemical Journal · doi:10.1042/bj3430697 · Cited by 83
Martinis, B. S. D., & Bianchi, M. D. L. P. (2001) · Pharmacological Research · doi:10.1006/phrs.2001.0860 · Cited by 81
The protective effect of melatonin on cisplatin nephrotoxicity
Şener, G., Şatıroğlu, H., Kabasakal, L., et al. (2000) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2000.tb00440.x · Cited by 80
Yu, F. H. Z., Megyesi, J. K., Safirstein, R. L., & Price, P. M. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00101.2005 · Cited by 71
Schaaf, G., Maas-Bakker, R. F., de Groene, E. M., & Fink‐Gremmels, J. (2002) · Free Radical Research · doi:10.1080/1071576021000005267 · Cited by 71
Tumor necrosis factor-α in cisplatin nephrotoxicity: A homebred foe?
Dong, Z., & Atherton, S. S. (2007) · Kidney International · doi:10.1038/sj.ki.5002320 · Cited by 66
Self-citationLong-Term Renal Effect of Cisplatin in Man
Brilleta, G., Demya, G., Jacquiauda, C., et al. (1994) · American Journal of Nephrology · doi:10.1159/000168693 · Cited by 64
Endotoxin and cisplatin synergistically stimulate TNF-α production by renal epithelial cells
Ramesh, G., Kimball, S. R., Jefferson, L. S., & Reeves, W. B. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00277.2006 · Cited by 64
Xanthorrhizol has a potential to attenuate the high dose cisplatin-induced nephrotoxicity in mice
Kim, S. H., Hong, K. O., Hwang, J. K., et al. (2004) · Food and Chemical Toxicology · doi:10.1016/j.fct.2004.08.018 · Cited by 61
Cell cycle regulation: Repair and regeneration in acute renal failure
Price, P. M., Megyesi, J. K., & Safirstein, R. L. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.761_8.x · Cited by 59
Razzaque, M. S., Koji, T., Kumatori, A., et al. (1999) · Histochemistry and Cell Biology · doi:10.1007/s004180050368 · Cited by 59
Lu, C. Y., Hartono, J. R., Senitko, M., & Chen, J. (2007) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3280403c4e · Cited by 57
Zhou, H., Kato, A., Yasuda, H., Miyaji, T., Fujigaki, Y., Yamamoto, T., Yonemura, K., & Hishida, A. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.04.003 · Cited by 57
Biochemical and Molecular Mechanisms of Cisplatin Resistance
Siddik, Z. H. (2002) · Cancer treatment and research · doi:10.1007/978-1-4615-1173-1_13 · Cited by 55
Involvement of the CDK2-E2F1 pathway in cisplatin cytotoxicity in vitro and in vivo
Yu, F. Z., Megyesi, J. K., Safirstein, R. L., & Price, P. M. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00119.2007 · Cited by 53
Wang, J., Pabla, N., Wang, C., Wang, W., Schoenlein, P. V., & Dong, Z. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00509.2005 · Cited by 53
Self-citationCell cycle regulation: repair and regeneration in acute renal failure
Price, P. M., Megyesi, J. K., & Safirstein, R. L. (2003) · Seminars in Nephrology · doi:10.1016/s0270-9295(03)00087-1 · Cited by 45
Yang, C., Kaushal, V., Shah, S. V., & Kaushal, G. P. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00505.2006 · Cited by 44
Cisplatin Increases TNF-α mRNA Stability in Kidney Proximal Tubule Cells
Ramesh, G., & Reeves, W. B. (2006) · Renal Failure · doi:10.1080/08860220600843839 · Cited by 40
Sadzuka, Y., Shimizu, Y., Yoshio, T., & Hirota, S. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90274-7 · Cited by 33
Satoh, K., Wakui, H., Komatsuda, A., Nakamoto, Y., MIURA, A. B., Itoh, H., & Tashima, Y. (1994) · Renal Failure · doi:10.3109/08860229409044872 · Cited by 33
A cell cycle hypothesis of cooperative oncogenesis (Review)
Delaval, B., & Birnbaum, D. (2007) · International Journal of Oncology · doi:10.3892/ijo.30.5.1051 · Cited by 29
Wangila, G. W., Nagothu, K. K., Steward, R., Bhatt, R., Iyere, P. A., Willingham, W. M., Sorenson, J. R. J., Shah, S. V., & Portilla, D. (2006) · Toxicology in Vitro · doi:10.1016/j.tiv.2006.04.002 · Cited by 21
Cited by
Mechanisms of Cisplatin Nephrotoxicity
Miller, R. P., Tadagavadi, R. K., Ramesh, G., & Reeves, W. B. (2010) · Toxins · doi:10.3390/toxins2112490 · Cited by 1,622
Microbiota: a key orchestrator of cancer therapy
Roy, S., & Trinchieri, G. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.13 · Cited by 883
Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment
Jang, K.-J., Mehr, A. P., Hamilton, G. A., McPartlin, L. A., Chung, S., Suh, K.-Y., & Ingber, D. E. (2013) · Integrative Biology · doi:10.1039/c3ib40049b · Cited by 849
Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models
Brooks, C., Wei, Q., Cho, S.-G., & Dong, Z. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37829 · Cited by 735
Self-citationPathophysiology of Cisplatin-Induced Acute Kidney Injury
Ozkok, A., & Edelstein, C. L. (2014) · BioMed Research International · doi:10.1155/2014/967826 · Cited by 703
Metadata
- Authors
- Pabla, N., & Dong, Z.
- Venue
- Kidney International
- Publisher
- Elsevier BV
- Published
- 2008-05
- Volume
- 73
- Issue
- 9
- Pages
- 994-1007
- ISSN
- 0085-2538 (ISSN-L)
- OpenAlex
- W1983965827
- Cited by
- 1,918
- References
- 127
- FWCI
- 30.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.